Literature DB >> 9190110

Tumor antigens recognized by T cells.

T Boon1, P G Coulie, B Van den Eynde.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9190110     DOI： 10.1016/s0167-5699(97)80020-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  104 in total

1.  Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC).

Authors:  K J Palmer; M Harries; M E Gore; M K Collins
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  Antigen-recognition properties of murine gamma delta T cells.

Authors:  Y H Chien; J Hampl
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Development of effective immunotherapy for the treatment of patients with cancer.

Authors:  Steven A Rosenberg
Journal:  J Am Coll Surg       Date:  2004-05       Impact factor: 6.113

Review 4.  Immunoinformatics: an integrated scenario.

Authors:  Namrata Tomar; Rajat K De
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

5.  Helicobacter pylori, a carcinogen, induces the expression of melanoma antigen-encoding gene (Mage)-A3, a cancer/testis antigen.

Authors:  Takashi Fukuyama; Taiga Yamazaki; Tomoko Fujita; Takayuki Uematsu; Yoshinobu Ichiki; Hiroshi Kaneko; Tatsuo Suzuki; Noritada Kobayashi
Journal:  Tumour Biol       Date:  2012-07-07

Review 6.  [Expression of cancer testis (CT) antigens in pediatric and adolescent melanomas].

Authors:  N Behrendt; T Schultewolter; K Busam; D Frosina; G Spagnoli; A Jungbluth
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

7.  Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer.

Authors:  K Leelawat; T Watanabe; M Nakajima; S Tujinda; C Suthipintawong; V Leardkamolkarn
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 8.  Dendritic cell based vaccination strategy: an evolving paradigm.

Authors:  Anna C Filley; Mahua Dey
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

9.  Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

Authors:  Maria R Parkhurst; Cormac DePan; John P Riley; Steven A Rosenberg; Suyu Shu
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

10.  In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).

Authors:  Malarvizhi Durai; Christine Krueger; Zhaohui Ye; Linzhao Cheng; Andreas Mackensen; Mathias Oelke; Jonathan P Schneck
Journal:  Cancer Immunol Immunother       Date:  2008-06-18       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.